These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 36321921

  • 1. Correlating Psychotropic Use to Major Depressive Disorder and ADHD Research Diagnoses: Trends in a Prospective Pediatric Cohort From Ages 3 to 21.
    Liang MU, Charatcharungkiat N, Tillman R, Patel HM, Vogel AC, Luby JL.
    J Clin Psychiatry; 2022 Oct 31; 83(6):. PubMed ID: 36321921
    [Abstract] [Full Text] [Related]

  • 2. The Prevalence of Stimulant and Antidepressant Use by Australian Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Major Depressive Disorder: A National Survey.
    Sawyer MG, Reece CE, Sawyer AC, Johnson S, Lawrence D, Zubrick SR.
    J Child Adolesc Psychopharmacol; 2017 Mar 31; 27(2):177-184. PubMed ID: 27154239
    [Abstract] [Full Text] [Related]

  • 3. Psychiatric comorbidity in children and adolescents with restless legs syndrome: a retrospective study.
    Pullen SJ, Wall CA, Angstman ER, Munitz GE, Kotagal S.
    J Clin Sleep Med; 2011 Dec 15; 7(6):587-96. PubMed ID: 22171196
    [Abstract] [Full Text] [Related]

  • 4. Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers.
    Winterstein AG, Soria-Saucedo R, Gerhard T, Correll CU, Olfson M.
    J Clin Psychiatry; 2017 Jul 15; 78(7):e744-e781. PubMed ID: 28686819
    [Abstract] [Full Text] [Related]

  • 5. Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.
    Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.
    Pediatrics; 2002 May 15; 109(5):733-9. PubMed ID: 11986429
    [Abstract] [Full Text] [Related]

  • 6. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS, Wang S, Crystal S, Olfson M.
    JAMA Netw Open; 2019 Jul 03; 2(7):e197850. PubMed ID: 31348506
    [Abstract] [Full Text] [Related]

  • 7. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
    Comer JS, Olfson M, Mojtabai R.
    J Am Acad Child Adolesc Psychiatry; 2010 Oct 03; 49(10):1001-10. PubMed ID: 20855045
    [Abstract] [Full Text] [Related]

  • 8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF, Miller A, Fine S.
    Pediatrics; 2004 Nov 03; 114(5):e541-7. PubMed ID: 15520087
    [Abstract] [Full Text] [Related]

  • 9. Occult mood disorders in 104 consecutively presenting children referred for the treatment of attention-deficit/hyperactivity disorder in a community mental health clinic.
    Dilsaver SC, Henderson-Fuller S, Akiskal HS.
    J Clin Psychiatry; 2003 Oct 03; 64(10):1170-6; quiz, 1274-6. PubMed ID: 14658964
    [Abstract] [Full Text] [Related]

  • 10. Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.
    Fullerton CA, Epstein AM, Frank RG, Normand SL, Fu CX, McGuire TG.
    Psychiatr Serv; 2012 Feb 01; 63(2):115-21. PubMed ID: 22302327
    [Abstract] [Full Text] [Related]

  • 11. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
    Radigan M, Lannon P, Roohan P, Gesten F.
    J Child Adolesc Psychopharmacol; 2005 Feb 01; 15(1):44-56. PubMed ID: 15741785
    [Abstract] [Full Text] [Related]

  • 12. Very early predictors of adolescent depression and suicide attempts in children with attention-deficit/hyperactivity disorder.
    Chronis-Tuscano A, Molina BS, Pelham WE, Applegate B, Dahlke A, Overmyer M, Lahey BB.
    Arch Gen Psychiatry; 2010 Oct 01; 67(10):1044-51. PubMed ID: 20921120
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Psychiatric comorbidities in children with attention deficit hyperactivity disorder: implications for management.
    Pliszka SR.
    Paediatr Drugs; 2003 Oct 01; 5(11):741-50. PubMed ID: 14580223
    [Abstract] [Full Text] [Related]

  • 19. ADHD Treatment in Primary Care: Demographic Factors, Medication Trends, and Treatment Predictors.
    Hauck TS, Lau C, Wing LLF, Kurdyak P, Tu K.
    Can J Psychiatry; 2017 Jun 01; 62(6):393-402. PubMed ID: 28103079
    [Abstract] [Full Text] [Related]

  • 20. Co-occurring weight problems among children with attention deficit/hyperactivity disorder: the role of executive functioning.
    Graziano PA, Bagner DM, Waxmonsky JG, Reid A, McNamara JP, Geffken GR.
    Int J Obes (Lond); 2012 Apr 01; 36(4):567-72. PubMed ID: 22158266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.